ConductScience.org, home

Paper39300073

The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.

Shan Q and 22 others. Signal Transduct Target Ther, 2024. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma. Papers, record 39300073. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39300073

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
PubMed
Journal
Signal Transduct Target Ther
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
8.07, provisional
iCite
Revised in PubMed
2025-07-29
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shan QQiaonan
2Yin LLu
3Zhan QQifan
4Yu JJiongjie
5Pan SSheng
6Zhuo JJianyong
7Zhou WWei
8Bao JJiaqi
9Zhang LLincheng
10Hong JJiachen
11Xiang JJianan
12Que QQingyang
13Chen KKangchen
14Xu SShengjun
15Wang JJingrui
16Zhu YYangbo
17He BBin
18Wu JJingbang
19Xie HHaiyang
20Zheng SShusen

Source PubMed

See all 23 authorsDownload CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
QuinolinesMajor topic
Liver NeoplasmsMajor topic
Hypoxia-Inducible Factor 1, alpha SubunitMajor topic
Phenylurea CompoundsMajor topic
Drug Resistance, NeoplasmMajor topic
Ubiquitin ThiolesteraseMajor topic
Neoplastic Stem CellsMajor topic
Humans
Myosin Heavy Chains
Mice
Cell Line, Tumor
Animals
Gene Expression Regulation, Neoplastic
Male

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
92159202National Natural Science Foundation of China (National Science Foundation of China)PubMed
82203070National Natural Science Foundation of China (National Science Foundation of China)PubMed
82200727National Natural Science Foundation of China (National Science Foundation of China)PubMed
82200726National Natural Science Foundation of China (National Science Foundation of China)PubMed
82273270National Natural Science Foundation of China (National Science Foundation of China)PubMed

Source PubMed

Download CSV of grants

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131622608Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.Life Sci2019https://conductscience.org/library/papers/31622608PubMed
229307467Hepatocellular carcinoma.Lancet2018https://conductscience.org/library/papers/29307467PubMed
333832339Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA.Future Oncol2021https://conductscience.org/library/papers/33832339PubMed
439068164DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway.Cell Death Dis2024https://conductscience.org/library/papers/39068164PubMed
537117273Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression.Cell Death Differ2023https://conductscience.org/library/papers/37117273PubMed
638045832Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.MedComm (2020)2023https://conductscience.org/library/papers/38045832PubMed
724436421Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.Science2014https://conductscience.org/library/papers/24436421PubMed
835683032
Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.
Int J Mol Sci2022https://conductscience.org/library/papers/35683032PubMed
937482600Application of multi-modality MRI-based radiomics in the pre-treatment prediction of RPS6K expression in hepatocellular carcinoma.Mol Biomed2023https://conductscience.org/library/papers/37482600PubMed
1039156893Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis.Front Immunol2024https://conductscience.org/library/papers/39156893PubMed
1125453096Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25453096PubMed
1217567956Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells.Mol Biol Cell2007https://conductscience.org/library/papers/17567956PubMed
1338634741Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-κB signaling pathway leads to the formation of a loop between HIF-1α and MUC1-C promoting chemoresistance in bladder cancer.Mol Carcinog2024https://conductscience.org/library/papers/38634741PubMed
1438241695N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.Cancer Res2024https://conductscience.org/library/papers/38241695PubMed
1535767704Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma.Cancer Res2022https://conductscience.org/library/papers/35767704PubMed
1634470658The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34470658PubMed
1735124127Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis.J Control Release2022https://conductscience.org/library/papers/35124127PubMed
1837935888Deubiquitinases in cancer.Nat Rev Cancer2023https://conductscience.org/library/papers/37935888PubMed
1939149512Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities.Front Cell Dev Biol2024https://conductscience.org/library/papers/39149512PubMed
2039060914Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA).Cell Biochem Biophys2024https://conductscience.org/library/papers/39060914PubMed

See all 43 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
42934489Tip60-Mediated USP22 Lactylation Drives Glutamine Metabolic Reprogramming via SLC25A5 in TNBC.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42934489PubMed
42928059Tumor-derived annexin A1 drives lenvatinib resistance by regulating SOX2/STAT3/S100A6 feedback loop and M2 macrophage polarization in hepatocellular carcinoma.Cell Death Dis2026https://conductscience.org/library/papers/42928059PubMed
42890758MYH9 confers doxorubicin resistance by stabilizing GRP78 and suppressing the PERK signaling-driven apoptotic pathway in breast cancer.Front Oncol2026https://conductscience.org/library/papers/42890758PubMed
42859251E3 ubiquitin ligase-mediated necroptosis: regulatory mechanisms and therapeutic implication in cancer.Mol Biol Rep2026https://conductscience.org/library/papers/42859251PubMed
42850382LAIR1 suppresses phagocytosis via SHP2/USP22-mediated MYH9 degradation in glioma-associated microglia/macrophages to drive immunosuppression.Br J Cancer2026https://conductscience.org/library/papers/42850382PubMed
42794777Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases.Int J Mol Sci2026https://conductscience.org/library/papers/42794777PubMed
42770181Exosomal circ-ZNF652 Mediates TGF-β1-Induced Epithelial-Mesenchymal Transition and Glycolytic Reprogramming to Promote Hepatocellular Carcinoma Progression.J Microbiol Biotechnol2026https://conductscience.org/library/papers/42770181PubMed
42724826Hypoxia-inducible factor-1α promotes the malignant progression of cervical cancer cells by regulating lactate dehydrogenase A-mediated glycolysis.Transl Cancer Res2026https://conductscience.org/library/papers/42724826PubMed
42687478Stemness plasticity in hepatocellular carcinoma: spatial niches and therapeutic implications.J Liver Cancer2026https://conductscience.org/library/papers/42687478PubMed
42592210HIFs: The central drivers of tumors and their role as molecular switches in targeted therapy?Acta Pharm Sin B2026https://conductscience.org/library/papers/42592210PubMed
42415626Remodelling the tumour microenvironment and beyond: ERO1A as a multifaceted regulator and emerging therapeutic target in cancer.Clin Transl Med2026https://conductscience.org/library/papers/42415626PubMed
42404106Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42404106PubMed
42394399Review Article: Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine.Aliment Pharmacol Ther2026https://conductscience.org/library/papers/42394399PubMed
42373728GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma.NPJ Precis Oncol2026https://conductscience.org/library/papers/42373728PubMed
42360649Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma.Med Oncol2026https://conductscience.org/library/papers/42360649PubMed
42263684SPACE-seq integrates spatial transcriptomics and lineage tracing in native tissues.Cell Stem Cell2026https://conductscience.org/library/papers/42263684PubMed
42220612Calcium peroxide loaded liposomes reprogram hypoxic and acidic tumor microenvironment to overcome lenvatinib resistance in hepatocellular carcinoma.Mater Today Bio2026https://conductscience.org/library/papers/42220612PubMed
42207429Understanding how hypoxia contributes to liver cancer stem cells maintenance.Clin Transl Oncol2026https://conductscience.org/library/papers/42207429PubMed
42192118Activation of methionine metabolism mediated by HNF4α confers ferroptosis resistance in hepatocellular carcinoma.Cell Death Discov2026https://conductscience.org/library/papers/42192118PubMed
42174129FLRT2 promotes foam cell formation and atherosclerosis by inhibiting USP22-mediated ABCA1 deubiquitination.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42174129PubMed

See all 52 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
MYH94627PubTator's text mininghttps://conductscience.org/library/genes/4627NCBI Gene
USP2223326PubTator's text mininghttps://conductscience.org/library/genes/23326NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39300073

GET https://conductscience.org/api/papers/v1/39300073/authors?page=2